UCB and Domino Data Lab Partner to Modernise Statistical Computing in Life Sciences
Tuesday, May 20, 2025
UCB has entered a strategic collaboration with Domino Data Lab to upgrade its Statistical Computing Environment (SCE) for life sciences. The initiative is focused on transforming outdated systems into a unified, scalable, and flexible platform to better support clinical research, regulatory needs, and data analysis.
The partnership will introduce a modern, cloud-based environment that supports a range of analytical tools including SAS, R, and Python. By combining Domino’s expertise in cloud and open-source technologies with UCB’s experience in clinical research and regulatory standards, the project aims to boost research capabilities while ensuring compliance with regulations such as GxP, FDA 21 CFR Part 11, and GDPR.
The new environment will include embedded metadata and workflow management features, helping to improve data searchability and promote responsible data reuse. This is expected to speed up drug development processes and support data-driven decision-making.
The collaboration supports UCB’s wider strategy to use innovative platforms and technologies to explore disease mechanisms, understand patient groups, and accelerate research pipelines. Researchers and data scientists will benefit from streamlined access to tools, enabling faster development of targeted therapies for serious diseases.
By contributing to wider industry efforts such as PHUSE and the SCE Coalition, the partnership also aims to encourage open-source practices and help set new standards for efficient, compliant statistical environments.
Overall, the initiative reflects a shared commitment to driving innovation and improving outcomes across the life sciences sector.
Source: ucb.com
